MOG and myeloid sarcoma: Among them, one reference related to the diagnostic of MS [17], five references related to MOGAD, one related to eculizumab treatment in AQP4-NMOSD [18], and the other one highlighted the importance of early treatment for the long-term visual recovery in ON with AQP4 and MOG immunoglobulin (IgG) [19].